ES8800937A1 - Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona - Google Patents

Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Info

Publication number
ES8800937A1
ES8800937A1 ES554432A ES554432A ES8800937A1 ES 8800937 A1 ES8800937 A1 ES 8800937A1 ES 554432 A ES554432 A ES 554432A ES 554432 A ES554432 A ES 554432A ES 8800937 A1 ES8800937 A1 ES 8800937A1
Authority
ES
Spain
Prior art keywords
tricyclic pyridone
pyridone derivatives
formula
tricyclic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554432A
Other languages
English (en)
Other versions
ES554432A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8800937A1 publication Critical patent/ES8800937A1/es
Publication of ES554432A0 publication Critical patent/ES554432A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE BI- Y TRICICLICOS DE PIRIDONA. CONSISTENTE EN HACER REACCIONAR EL COMPUESTO DE FORMULA (II) CON UNA AMINA DE FORMULA HNR3R4 PARA OBTENER EL COMPUESTO (I) Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES. SIENDO: Q1, FNCH2-CH2- Y OTROS; RA, FENILO, TIENILO Y OTROS; RB Y RC, H, HAL Y OTROS; RD, -(A1)M-(Q2A2)-R1; A1, ALQUILENO INFERIOR; A2, -CO-; Q2, ATOMO DE OXIGENO; R1, NR3R4; R3 Y R4, H, ALQUILO INFERIOR Y OTROS; X2, FENOXILO. SE UTILIZA COMO FARMACO ANTICONVULSIVO.
ES554432A 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona Expired ES8800937A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH530484 1984-11-06
CH383685 1985-09-05

Publications (2)

Publication Number Publication Date
ES8800937A1 true ES8800937A1 (es) 1987-12-01
ES554432A0 ES554432A0 (es) 1987-12-01

Family

ID=25693960

Family Applications (8)

Application Number Title Priority Date Filing Date
ES548532A Expired ES8705436A1 (es) 1984-11-06 1985-11-05 Un procedimiento para la obtencion de derivados de bi- y triciclicosdde piridona
ES554431A Expired ES8800936A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554427A Expired ES8800933A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554428A Expired ES8800934A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554430A Expired ES8800939A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554426A Expired ES8800932A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554429A Expired ES8800935A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554432A Expired ES8800937A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Family Applications Before (7)

Application Number Title Priority Date Filing Date
ES548532A Expired ES8705436A1 (es) 1984-11-06 1985-11-05 Un procedimiento para la obtencion de derivados de bi- y triciclicosdde piridona
ES554431A Expired ES8800936A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554427A Expired ES8800933A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554428A Expired ES8800934A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554430A Expired ES8800939A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554426A Expired ES8800932A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554429A Expired ES8800935A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Country Status (23)

Country Link
US (2) US4735940A (es)
EP (2) EP0183994B1 (es)
JP (1) JPH0692405B2 (es)
CN (1) CN1016871B (es)
AR (1) AR242579A1 (es)
AT (1) ATE51232T1 (es)
AU (1) AU584132B2 (es)
CA (1) CA1277659C (es)
DE (2) DE3576691D1 (es)
DK (1) DK507685A (es)
DO (1) DOP1985004378A (es)
ES (8) ES8705436A1 (es)
FI (1) FI89049C (es)
GB (1) GB2169288B (es)
HU (1) HU205353B (es)
IE (1) IE58850B1 (es)
IL (1) IL76894A (es)
IS (1) IS1469B6 (es)
MC (1) MC1707A1 (es)
MY (1) MY103172A (es)
NO (1) NO171914C (es)
PT (1) PT81431B (es)
ZW (1) ZW17385A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
CA1317945C (en) * 1985-12-13 1993-05-18 Ulf Fischer Tricyclic pyridazopyridone derivatives
EP0294599A3 (de) * 1987-06-12 1990-05-09 F. Hoffmann-La Roche Ag Tricyclische Pyridonderivate
ATE145208T1 (de) * 1990-07-06 1996-11-15 Yoshitomi Pharmaceutical Kondensierte thiophenverbindungen und deren verwendung
CA2058640A1 (en) * 1991-01-25 1992-07-26 Richard R. Scherschlicht Tricyclic pyridone derivative
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
FR2689129B1 (fr) * 1992-03-27 1995-05-12 Atochem Elf Sa Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease
GB9708945D0 (en) * 1997-05-01 1997-06-25 Merck Sharp & Dohme Therapeutic agents
GB0119803D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
GB0119828D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
US8178660B2 (en) 2006-01-13 2012-05-15 The Trustees Of The University Of Pennsylvania Vaccines and immunotherapeutics using codon optimized IL-15 and methods for using the same
RS59991B1 (sr) 2013-08-08 2020-04-30 Scripps Research Inst Metoda enzimskog in vitro obeležavanja specifičnog za položaj nukleinskih kiselina uvođenjem neprirodnih nukleotida

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191763A (en) * 1978-10-13 1984-05-31 Hoffmann La Roche 7-beta-phenyl-quinolidines, intermediates and pharmaceutical compositions
EP0067565A1 (en) * 1981-06-16 1982-12-22 Beecham Group Plc Pharmaceutically active compounds
GB8408292D0 (en) * 1984-03-30 1984-05-10 Fujisawa Pharmaceutical Co Quinolizinone compound
GB8420602D0 (en) * 1984-08-14 1984-09-19 Wyeth John & Brother Ltd Thienoquinolizines
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
GB8509435D0 (en) * 1985-04-12 1985-05-15 Beecham Group Plc Intermediates & process
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines

Also Published As

Publication number Publication date
EP0318682B1 (de) 1993-03-31
AR242579A1 (es) 1993-04-30
DE3587235D1 (en) 1993-05-06
ZW17385A1 (en) 1986-02-19
ES554428A0 (es) 1987-12-01
GB8527196D0 (en) 1985-12-11
ES8800939A1 (es) 1987-12-01
PT81431B (pt) 1988-03-03
ES548532A0 (es) 1987-05-01
ES8800933A1 (es) 1987-12-01
PT81431A (en) 1985-12-01
IL76894A (en) 1989-06-30
CN85108120A (zh) 1986-11-05
ES8800935A1 (es) 1987-12-01
CA1277659C (en) 1990-12-11
ES8800934A1 (es) 1987-12-01
HU205353B (en) 1992-04-28
HUT38638A (en) 1986-06-30
US4735940A (en) 1988-04-05
FI854211A0 (fi) 1985-10-28
IS3054A7 (is) 1986-05-07
EP0183994B1 (de) 1990-03-21
AU584132B2 (en) 1989-05-18
ES554430A0 (es) 1987-12-01
DK507685D0 (da) 1985-11-04
AU4924185A (en) 1986-05-15
MY103172A (en) 1993-05-29
ES554426A0 (es) 1987-12-01
EP0318682A2 (de) 1989-06-07
JPS61115082A (ja) 1986-06-02
NO171914C (no) 1993-05-19
DK507685A (da) 1986-05-07
IL76894A0 (en) 1986-02-28
ATE51232T1 (de) 1990-04-15
GB2169288B (en) 1989-06-01
ES8705436A1 (es) 1987-05-01
ES554431A0 (es) 1987-12-01
IS1469B6 (is) 1991-09-24
FI89049B (fi) 1993-04-30
EP0318682A3 (en) 1989-08-16
EP0183994A1 (de) 1986-06-11
NO171914B (no) 1993-02-08
CN1016871B (zh) 1992-06-03
NO854404L (no) 1986-05-07
IE852751L (en) 1986-05-06
DE3576691D1 (de) 1990-04-26
JPH0692405B2 (ja) 1994-11-16
IE58850B1 (en) 1993-11-17
FI89049C (fi) 1993-08-10
ES8800936A1 (es) 1987-12-01
DOP1985004378A (es) 1991-04-05
GB2169288A (en) 1986-07-09
ES554432A0 (es) 1987-12-01
ES8800932A1 (es) 1987-12-01
US5036066A (en) 1991-07-30
MC1707A1 (fr) 1986-09-22
ES554429A0 (es) 1987-12-01
ES554427A0 (es) 1987-12-01

Similar Documents

Publication Publication Date Title
AR241528A1 (es) Un procedimiento para la preparacion de n-(3- o 4-((alquilamino)alquil)-fenil)alcansulfonamidas y sus sales.
ES8605500A1 (es) Procedimiento para preparar derivados de acidos fenilaceticos.
ES464162A1 (es) Procedimiento para la preparacion de derivados de quinazolo-na.
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
ES2073398T3 (es) Nuevos derivados substituidos del acido bencilideno- y cinamilideno-malonico con actividad como inhibidores de la proliferacion celular.
FI810250L (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva heterocykliska foereningar
ES8306753A1 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
ES8800936A1 (es) Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES430119A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-fenilamino-imidazolina-(2).
PT81004B (pt) Processo para a preparacao de oxindoles trigiclicos uteis como agentes anti-inflamatorios
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
AU6517086A (en) Phenoxy substituted beta-carboline derivatives, their production and their use as drugs
ES2066853T3 (es) Procedimiento para la produccion de o2,2'-anhidro-1-(beta-d-arabinofuranosil)timina.
DK391182A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse
DK37580A (da) 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater samt deres fremstilling og anvendelse
ATE88467T1 (de) Pharmakologisch aktive alkylol-derivate.
ES2019871B3 (es) 1,2,3,4,4a,9b-hexahidro-4a-aminoalquildibenzofuranos, un proceso para su preparacion y su uso como medicamentos.
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
DE68921198D1 (de) Benzothiadiazepin-derivate.
ES2056072T3 (es) Procedimientos de preparacion del acido (+/-)-1,2-dihidro-3h-pirrolo (1,2-a) pirrol-1-carboxilico y compuestos relacionados.
ES425010A1 (es) Procedimiento para la preparacion de n-(heteroaril-metil)- 6,14-endoetno-7 a-hidrovialcohil-tetrahidro-nororipavinas y tebainas.
ES424309A1 (es) Procedimiento para la preparacion de n-(heteroarilmetil)-7 -acil-6,14-endoetenotetrahidronororipavinas y -tebainas.
ES8502115A1 (es) Procedimiento para preparar nuevos 4-hidroxi-2h-1, 2-benzotiazin-3-carboxamido-1, 1-dioxidos
ES394409A1 (es) Un procedimiento para la preparacion de derivados de 5n-o- xido de triazolbenzodiazepina.